Genomic Health Announces Colon Cancer Publication in Journal of Clinical Oncology Supporting Wider Oncotype DXÂ® Utilization
REDWOOD CITY, Calif., Nov. 13, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) has published positive results from a large, independent validation study of the Oncotype DX® colon cancer test in patients from the National Surgical Adjuvant Breast and Bowel Project (NSABP) C-07 clinical trial.
Genomic Health Announces Colon Cancer Publication Supporting Wider Oncotype DXÂ® Utilization
REDWOOD CITY, Calif., Nov. 5, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Current Medical Research & Opinion (CMRO) published positive results from the Partnership for Health Analytic Research (PHAR) clinical utility analysis of the Oncotype DX® colon cancer test, demonstrating that use of the assay changes treatment recommendations in 29 percent of stage II colon cancer patients.
"We now have eight peer-reviewed publications that reinforce the value Oncotype DX provides to physicians, colon cancer patients and our healthcare system," said Steven Shak, M.D., executive vice president of research and development, Genomic Health. "With ...
New CDC Report Shows Colorectal Cancer Tests are Underused: 23 Million American Adults Have Never Been Tested
BETHESDA, Md., Nov. 5, 2013 /PRNewswire-USNewswire/ -- Colorectal cancer screening (CRC) rates remain too low, with about one in three adults (ages 50 to 75 years) not being tested for colorectal cancer, according to a new Vital Signs report from the Centers for Disease Control and Prevention (CDC).
The CDC's Vital Signs report also found that 23 million adults in the United States have not had the recommended screenings despite research showing colorectal cancer tests save lives.
Board-Certified Gastroenterologist Explains Why Colon Cancer Screening Participation Lags Behind that of Breast Cancer Screening
DALLAS, Oct. 28, 2013 /PRNewswire/ -- With October being national breast cancer awareness month, it's difficult to not be constantly reminded of "thinking pink" with the great job the organizations and survivors do in promoting this awareness message. That awareness has been exponentially increased with the celebrity and sports relationships as well. For example, professional and college football players are wearing pink equipment during nationally televised games to raise awareness in October.
In the U.S., 72% of women report being up-to-date on their breast health screenings while only a little more than half could say the same about colon cancer screenings.
Colon Cancer Challenge Foundation Gives Award for Excellence in Colorectal Cancer Research
NEW YORK, Oct. 22, 2013 /PRNewswire/ -- The Colon Cancer Challenge Foundation (CCCF), a New York-based nonprofit dedicated to reducing colorectal cancer incidence and death throughout the United States, has given the Colon Cancer Challenge Foundation/CGA-ICC Colorectal Cancer Research Scholar Award to Deborah Cragun.
The award is given to the top-ranking abstract submitted by a trainee or junior faculty member.
Biocartis and Hospital del Mar (Barcelona, Spain) Join Forces to Develop Diagnostic Colon Cancer Test
LAUSANNE, Switzerland, MECHELEN, Belgium and BARCELONA, Spain, October 17, 2013 /PRNewswire/ --
Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer.